SCHEMBL3205149

SCHEMBL3205149

CCOC(=O)C(C(C)C)N1CC=CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
LMNA P02545 3/20 0.45
MAPT P10636 1/20 0.45
HPGD P15428 1/20 0.45
RAB9A P51151 1/20 0.45
KMT2A Q03164 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
CASP6 P55212 1/20 0.38
DPP4 P27487 3/20 0.36
DPP8 Q6V1X1 2/20 0.36
DPP9 Q86TI2 1/20 0.36
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
GAA P10253 2/20 0.34
TSHR P16473 1/20 0.34
HSD17B10 Q99714 1/20 0.33
PIN1 Q13526 1/20 0.33
CYP1A2 P05177 1/20 0.33
LPO P22079 1/20 0.33
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13484647 1.00 ALDH1A1 (0.45) ALDH1A1LMNAMAPTHPGDRAB9A
SCHEMBL3209999 0.82 TSHR (0.41) ALDH1A1LMNAMAPTHPGDRAB9A
SCHEMBL13484645 0.82 TSHR (0.41) ALDH1A1LMNAMAPTHPGDRAB9A
SCHEMBL17111315 0.73 ALDH1A1 (0.38) ALDH1A1LMNAMAPTHPGDRAB9A
SCHEMBL31503973 0.69 TSHR (0.50) ALDH1A1LMNAMAPTKMT2AGAA
SCHEMBL8436272 0.69 ALDH1A1 (0.42) ALDH1A1LMNAMAPTKMT2AGAA
SCHEMBL1289807 0.68 ALDH1A1 (0.37) ALDH1A1LMNAMAPTHPGDRAB9A
SCHEMBL31042787 0.67 ALDH1A1 (0.40) ALDH1A1LMNAMAPTHPGDRAB9A
SCHEMBL6129180 0.67 ALDH1A1 (0.46) ALDH1A1LMNAMAPTHPGDRAB9A
SCHEMBL30896725 0.66 POLB (0.35) ALDH1A1LMNAMAPTHPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029738-A1 Bicyclic Tetrahydropyrrole Compounds LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2010-02-04 US claimed
EP-2029536-A1 BICYCLIC TETRAHYDROPYRROLE COMPOUNDS Laboratorios Del. Dr. Esteve, S.A. (ES) 2009-03-04 EP claimed
WO-2007128458-A1 BICYCLIC TETRAHYDROPYRROLE COMPOUNDS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-11-15 WO claimed
EP-2029536-B1 BICYCLIC TETRAHYDROPYRROLE COMPOUNDS ESTEVE LABOR DR (ES) 2013-08-28 EP disclosed
US-8299113-B2 Bicyclic tetrahydropyrrole compounds LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2012-10-30 US disclosed
US-20100029738-A1 Bicyclic Tetrahydropyrrole Compounds LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2010-02-04 US disclosed
EP-2029536-A1 BICYCLIC TETRAHYDROPYRROLE COMPOUNDS Laboratorios Del. Dr. Esteve, S.A. (ES) 2009-03-04 EP disclosed
WO-2007128458-A1 BICYCLIC TETRAHYDROPYRROLE COMPOUNDS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-11-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029738-A1 Bicyclic Tetrahydropyrrole Compounds CYP11B2, CYP11B1, SDHA ALDH1A1 586/4885LMNA 2795/4885MAPT 1219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.